Veristat promotes seasoned drug developer to chief commercial officer
Photo | Courtesy of Veristat
Cindy Henderson is now chief commercial officer at Veristat.
Veristat, the Southborough-based global clinical research organization, has promoted Cindy Henderson to the role of chief commercial officer.
Henderson, a 15-year veteran of Veristat who previously worked as executive vice president, strategic development at the company, will drive business expansion and execute on growth opportunities in her new role, according to the Tuesday announcement from Veristat. She will continue to oversee all commercial functions at the company, including strategy, proposals and contracts, business development, and commercial operations and marketing.
In her 15-year career at Veristat, Henderson has led operational teams, supported eight global acquisitions, and created a go-to-market strategy which has solidified the company’s position as a provider of clinical development and regulatory solutions. She has been involved in bringing more than 40 drugs to market.
She has 30 years of experience in the field, including as senior manager of training, innovations, and processes at Virginia-based Averion International Corp., now known as ICON.
WBJ Web Partners
Most Recent
Most Recent
0 Comments